substance p has been researched along with Laryngitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, A; Baltazar, F; Castro, AG; Cruz, A; Lamas, N; Lima-Rodrigues, M; Oliveira, P; Pedrosa, J; Reis, RM; Valle-Fernandes, A; Vieira, A | 1 |
| Almeida, A; Baltazar, F; Castro, AG; Cruz, A; Lamas, N; Lima-Rodrigues, M; Milanezi, F; Nunes, R; Pedrosa, J; Reis, RM; Valle-Fernandes, A | 1 |
2 other study(ies) available for substance p and Laryngitis
| Article | Year |
|---|---|
The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment.
Topics: Animals; Calcitonin Gene-Related Peptide; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Etoricoxib; Interleukin-10; Interleukin-1beta; Interleukin-6; Laryngitis; Male; Pyridines; Rats; Rats, Wistar; Substance P; Sulfones; Tumor Necrosis Factor-alpha | 2010 |
A new model of laryngitis: neuropeptide, cyclooxygenase, and cytokine profile.
Topics: Animals; Calcitonin Gene-Related Peptide; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Inflammation Mediators; Interleukin-10; Interleukin-1beta; Interleukin-6; Intubation, Gastrointestinal; Laryngeal Mucosa; Laryngitis; Male; Membrane Proteins; Neurons, Afferent; Neuropeptides; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Substance P; Time Factors; Tumor Necrosis Factor-alpha | 2008 |